These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 18297191)

  • 1. Genetic variations of EBV-LMP1 from nasopharyngeal carcinoma biopsies: potential loss of T cell epitopes.
    Tang YL; Lu JH; Cao L; Wu MH; Peng SP; Zhou HD; Huang C; Yang YX; Zhou YH; Chen Q; Li XL; Zhou M; Li GY
    Braz J Med Biol Res; 2008 Feb; 41(2):110-6. PubMed ID: 18297191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino acid changes in functional domains of latent membrane protein 1 of Epstein-Barr virus in nasopharyngeal carcinoma of southern China and Taiwan: prevalence of an HLA A2-restricted 'epitope-loss variant'.
    Lin JC; Cherng JM; Lin HJ; Tsang CW; Liu YX; Lee SP
    J Gen Virol; 2004 Jul; 85(Pt 7):2023-2034. PubMed ID: 15218188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional assays of HLA A2-restricted epitope variant of latent membrane protein 1 (LMP-1) of Epstein-Barr virus in nasopharyngeal carcinoma of Southern China and Taiwan.
    Lin HJ; Cherng JM; Hung MS; Sayion Y; Lin JC
    J Biomed Sci; 2005 Dec; 12(6):925-36. PubMed ID: 16307312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-Wide Analysis of 18 Epstein-Barr Viruses Isolated from Primary Nasopharyngeal Carcinoma Biopsy Specimens.
    Tu C; Zeng Z; Qi P; Li X; Yu Z; Guo C; Xiong F; Xiang B; Zhou M; Gong Z; Liao Q; Yu J; He Y; Zhang W; Li X; Li Y; Li G; Xiong W
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28637758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes.
    Khanna R; Burrows SR; Nicholls J; Poulsen LM
    Eur J Immunol; 1998 Feb; 28(2):451-8. PubMed ID: 9521052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
    Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
    Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sequence analysis of the CTL epitopes in transmembrane region of latent membrane protein 2 of Epstein-Barr virus derived from nasopharyngeal carcinoma cells].
    Zhang NH; Zhang XS; Li J; Zhang RH; Gao YF; Zeng MS
    Ai Zheng; 2006 May; 25(5):566-9. PubMed ID: 16687075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong.
    Cheung ST; Leung SF; Lo KW; Chiu KW; Tam JS; Fok TF; Johnson PJ; Lee JC; Huang DP
    Int J Cancer; 1998 May; 76(3):399-406. PubMed ID: 9579578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of sequence variations of Epstein-Barr virus LMP1 gene in nasopharyngeal carcinoma].
    Lin SX; Zong YS; Zhang M; Han AJ; Zhong BL; Liang YJ
    Zhonghua Bing Li Xue Za Zhi; 2005 Dec; 34(12):791-5. PubMed ID: 16545188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of Epstein-Barr virus with BamHI "f" variant and XhoI-loss of LMP1 gene in nasopharyngeal carcinoma].
    Han AJ; Zong YS; Zhang M; Cao SM; Lin SX; Liang YJ
    Zhonghua Bing Li Xue Za Zhi; 2003 Dec; 32(6):534-8. PubMed ID: 14761599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic LMP1 polyepitope vaccine for EBV-associated Hodgkin disease and nasopharyngeal carcinoma.
    Duraiswamy J; Sherritt M; Thomson S; Tellam J; Cooper L; Connolly G; Bharadwaj M; Khanna R
    Blood; 2003 Apr; 101(8):3150-6. PubMed ID: 12468425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The LMP1 gene isolated from Russian nasopharyngeal carcinoma has no 30-bp deletion.
    Hahn P; Novikova E; Scherback L; Janik C; Pavlish O; Arkhipov V; Nicholls J; Müller-Lantzsch N; Gurtsevitch V; Grässer FA
    Int J Cancer; 2001 Mar; 91(6):815-21. PubMed ID: 11275985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence variations of Epstein-Barr virus LMP1 gene in nasal NK/T-cell lymphoma.
    Nagamine M; Takahara M; Kishibe K; Nagato T; Ishii H; Bandoh N; Ogino T; Harabuchi Y
    Virus Genes; 2007 Jan; 34(1):47-54. PubMed ID: 16917737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleotide sequences and functions of the Epstein-Barr virus latent membrane protein 1 genes isolated from salivary gland lymphoepithelial carcinomas.
    Jen KY; Higuchi M; Cheng J; Li J; Wu LY; Li YF; Lin HL; Chen Z; Gurtsevitch V; Fujii M; Saku T
    Virus Genes; 2005 Mar; 30(2):223-35. PubMed ID: 15744579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4 and CD8 T cell responses to tumour-associated Epstein-Barr virus antigens in nasopharyngeal carcinoma patients.
    Lin X; Gudgeon NH; Hui EP; Jia H; Qun X; Taylor GS; Barnardo MC; Lin CK; Rickinson AB; Chan AT
    Cancer Immunol Immunother; 2008 Jul; 57(7):963-75. PubMed ID: 18094968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between EBNA2 and LMP1 subtypes of Epstein-Barr virus and nasopharyngeal carcinoma in Thais.
    Tiwawech D; Srivatanakul P; Karalak A; Ishida T
    J Clin Virol; 2008 May; 42(1):1-6. PubMed ID: 18180201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Various 30 and 69 bp deletion variants of the Epstein-Barr virus LMP1 may arise by homologous recombination in nasopharyngeal carcinoma of Tunisian patients.
    Hadhri-Guiga B; Khabir AM; Mokdad-Gargouri R; Ghorbel AM; Drira M; Daoud J; Frikha M; Jlidi R; Gargouri A
    Virus Res; 2006 Jan; 115(1):24-30. PubMed ID: 16154221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the Variability of Epstein-Barr Virus Genes in Nasopharyngeal Biopsies: Potential Predictors for Carcinoma Progression.
    Banko AV; Lazarevic IB; Folic MM; Djukic VB; Cirkovic AM; Karalic DZ; Cupic MD; Jovanovic TP
    PLoS One; 2016; 11(4):e0153498. PubMed ID: 27071030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 30-bp deletion variant: a polymorphism of latent membrane protein 1 prevalent in endemic and non-endemic areas of nasopharyngeal carcinomas in China.
    Zhang XS; Song KH; Mai HQ; Jia WH; Feng BJ; Xia JC; Zhang RH; Huang LX; Yu XJ; Feng QS; Huang P; Chen JJ; Zeng YX
    Cancer Lett; 2002 Feb; 176(1):65-73. PubMed ID: 11790455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of an XhoI-site within N-terminal region of Epstein-Barr virus LMP1 gene in nasopharyngeal carcinoma.
    Lin SX; Zong YS; Wu QL; Han AJ; Liang YJ
    Ai Zheng; 2003 Nov; 22(11):1147-51. PubMed ID: 14613641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.